Founded in Ithaca, New York, CyteQuest is dedicated to revolutionizing cell therapy production through innovative electroporation tools. Their core mission is to enhance the efficiency and accessibility of cell therapies by addressing current production challenges. CyteQuest offers a non-viral transfection platform that combines continuous flow with a microfluidic chip, making it a scalable and tunable solution for both research and manufacturing markets.
CyteQuest has garnered attention from notable figures in the biotech industry and has attracted significant investment to advance its technology. Their key achievements include the successful development and deployment of their electroporation tool, which has shown promise in improving the scalability and efficiency of cell therapy production. The overall impact of CyteQuest's innovations is poised to make cell therapies more accessible and affordable, potentially transforming treatment paradigms in various medical fields.
